Sokolove Law

Sokolove Law
About Us
Quotes
Share:
Subscribe:

About Us

Sokolove Law, LLC is the nation’s largest marketer of legal services that help people obtain access to the civil justice system while ensuring they receive superior quality legal representation. With over 30 years of service, Sokolove Law has helped thousands of injured parties obtain the compensation they deserve from their legal claim such as mesothelioma, cerebral palsy, nursing home abuse, dangerous drugs, disability insurance denial, and medical malpractice cases.

Quotes

“Our heartfelt condolences go out to Larry’s family. He was a great man who brought the Mesothelioma Community together around the country year in and year out in order to raise awareness of asbestos health dangers. We will honor Larry’s memory and tremendous community efforts by remaining committed to supporting the cause for which he was so passionate about.”

Jim Sokolove, Founder

“Sokolove Law is fortunate to have known Larry and we thank his daughter Courtney and the rest of the Davis family for sharing his story and impacting countless other lives around the country. He will be sorely missed.”

Ricky LeBlanc, Managing Attorney, Asbestos, Sokolove Law

For more than 30 years, Sokolove Law has helped children of families who have been impacted by cerebral palsy, Erb’s palsy (also known as Brachial Plexus injury), and other birth-related injuries. The firm has helped people in all 50 states get the legal support they need to move personal injury claims successfully through the court system. ChildBirthInjuries.com is great new resource for parents and their families.”

Jim Sokolove, founder

Pick a time period -

Tags ( Active)

All Regulatory Non-Regulatory

Pradaxa Has Risks—Should You Take It?

Fri, Jan 11, 2013 20:00 CET

Millions of Americans with an abnormal heart rhythm use the drug Pradaxa (dabigatran) daily to help prevent stroke and blood clotting. Since its approval in 2010, Pradaxa has been linked with numerous problems, including serious and potentially fatal bleeding. Pradaxa is not recommended for patients with mechanical heart valves or who are undergoing active bleeding. Additionally, the Mayo Clinic provides warnings about the use of Pradaxa in other groups, including: · Children. According to the Mayo

Feds Approve Pradaxa-like Drug

Tue, Jan 08, 2013 14:00 CET

The U.S. Food and Drug Administration (FDA) gave the green light to a new blood thinner called Eliquis, which will be used to treat some patients with atrial fibrillation, an irregular heartbeat condition. The FDA approval, which came last week, has the potential to turn Eliquis into a “blockbuster” for manufacturer Bristol-Myers Squibb and for Pfizer, which will market it, says an article

New Pradaxa Contraindication Coming

Fri, Jan 04, 2013 15:00 CET

Boehringer Ingelheim is warning doctors about using its Pradaxa (dabigatran) blood thinner drug for patients with mechanical heart valves. Pradaxa is used to prevent stroke and blood clots in patients with abnormal heart rhythm. However, Boehringer Ingelheim will issue a contraindication for patients with mechanical heart valves, according to a recent article

How Safe is Pradaxa?

Fri, Dec 21, 2012 15:00 CET

In October 2010, the U.S. Food and Drug Administration (FDA) approved Pradaxa capsules (dabigatran etexilate) to prevent stroke and blood clots in patients with abnormal heart rhythm (atrial fibrillation). Pradaxa replaced warfarin, an anti-coagulant drug that heart patients have used for decades. Certainly, Pradaxa has saved lives—patients taking it suffered fewer life-threatening or major bleeds (including intracranial bleeds) than patients using warfarin. But does this mean taking Pradaxa is safe for all patients? Unfortunately, no. Since Pradaxa’s FDA approval, there have been

One Lot of Pradaxa Recalled

Wed, Nov 28, 2012 14:00 CET

A single lot of Pradaxa 75 mg has been recalled due to a possible packaging defect which may cause moisture to get into the bottle, thereby affecting the safety and effectiveness of the drug. The affected lot belongs to: · NDC 0597-0149-54 · Lot #201900 · Expiration date: January 2015 MPR reports that Boehringer Ingelheim, the manufacturer of the anti-

Pradaxa Bleeding Risk Report Overlooks Lack of Antidote

Thu, Nov 08, 2012 23:00 CET

A new report released last week found that the anti-stroke medication Pradaxa does not pose a higher risk of serious bleeding in patients than its predecessor drug warfarin. But the report from the Food and Drug Administration (FDA) failed to address one critical fact about the two drugs: With Pradaxa, there is no antidote to stem a patient’s bleeding once complications arise, reports The

Judge Schedules Bellwether Trials for 2014 in Pradaxa MDL

Mon, Oct 29, 2012 23:00 CET

With at least 131 cases filed across 19 jurisdictions in the Pradaxa Multi-District Litigation (MDL), U.S. District Judge David Herndon issued the schedule for four "bellwether" trials to start in August 2014 and end in early 2015. Of those cases, 120 have been filed in the U.S. District Court for the Southern District of Illinois and 11 have been filed in state courts in California, Connecticut, and Illinois, reports The Madison-St. Clair

Pradaxa Problematic with Mechanical Heart Valves

Fri, Oct 19, 2012 00:00 CET

Off-label use of Pradaxa (dabigatran) is under scrutiny for potential problems related to its use in patients with mechanical heart valves. MedPage Today reports that there have been two case reports of blood clot formation in heart valve replacement patients who were prescribed Pradaxa after being on warfarin, another anti-stroke medication

Warning for Pradaxa Patients

Tue, Oct 02, 2012 20:00 CET

Philly.com is reporting that a drug commonly used to thin blood and prevent blood clots and strokes in patients with irregular heartbeats may have dangerous and even fatal side effects. Pradaxa, also known as dabigatran etexilate, is most often prescribed to patients with irregular heartbeats as a blood thinner to prevent strokes. The FDA is now reporting that Pradaxa has caused

Number of Pradaxa Lawsuits Continue to Grow

Mon, Oct 01, 2012 21:00 CET

Boehringer Ingelheim is in the spotlight because of its billion-dollar drug Pradaxa , and the wealth of dangerous drug lawsuits stemming from its adverse effects. Millions around the country take the anti-stroke drug every day, and almost 550 deaths associated with Pradaxa were reported last

Did FDA Know About Pradaxa Dangers?

Mon, Sep 24, 2012 18:00 CET

Pradaxa is one of three drugs that has been singled out in a new report that accuses the Food and Drug Administration of approving some medications to go on the market despite unresolved concerns about the dangerous drugs' safety. According to a report that was recently published in the

Pradaxa Used More for Off-Label Purposes

Fri, Sep 14, 2012 23:00 CET

Pradaxa - an anti-coagulant drug used for stroke reduction in atrial fibrillation (Afib) cases - is now being adopted more and more for off-label purposes, say researchers. MedPage Today reports that according to research published

Pradaxa MDL Continues To Grow

Thu, Sep 13, 2012 19:00 CET

The Pradaxa Multi District Litigation (MDL)—approved by the US Judicial Panel on Multidistrict Litigation (JPML) recently—has now grown to 78 cases in 19 jurisdictions. Pradaxa is a blood-thinning medication manufactured by Boehringer Ingelheim Pharmaceuticals

Pradaxa Lawsuit Filed Against Boehringer Ingelheim

Tue, Sep 04, 2012 22:30 CET

Yet another man has come forward with claims that Boehringer Ingelheim Pharmaceuticals hid the dangers of its anticoagulant drug Pradaxa and caused death and injury to thousands so they could generate massive sales. According to Courthouse News , Arthur Gabriel was prescribed Pradaxa in 2011 to help thin his blood and reduce the risk of stroke.

Pradaxa Lawsuit Filed in Tennessee

Tue, Sep 04, 2012 21:30 CET

In the wake of the recent consolidation of a number of Pradaxa lawsuits against Boehringer Ingelheim , we’ve been trying to find details about the cases wherever we can. One recent new story in The Tennessean profiled two men who both took the anticoagulant drug

Pradaxa Use Led to Health Issues

Tue, Aug 28, 2012 03:00 CET

A lawsuit has been filed by a former Pradaxa user that alleges the blood thinning drug has led to them requiring regular medical care and monitoring for the rest of their life. The Pradaxa lawsuit , which was filed against Boehringer Ingelheim on July 18, alleges that the victim began using the blood-thinning

Pradaxa Lawsuits Consolidated by JPML

Wed, Aug 15, 2012 22:00 CET

With at least 48 Pradaxa lawsuits filed across the country that accuse the Boehringer Ingelheim anticoagulant drug of causing dangerous excessive bleeding, the Judicial Panel on Multidistrict Litigation (JPML) has ordered that some of the cases be consolidated one courtroom. After hearing

UK Agency Updates Pradaxa Warnings

Wed, Aug 15, 2012 18:00 CET

A government agency based in the UK has updated its health warnings regarding Pradaxa (dabigatran ), suggesting that healthcare professional may not want to use the blood thinning medication

Louisiana Man Launches Pradaxa Lawsuit

Tue, Jul 10, 2012 17:00 CET

A Louisiana man is one of the latest patients who took the blood-thinning medication Pradaxa and suffered an adverse bleeding event to bring a dangerous drug lawsuit against Boehringer Ingelheim Pharmaceuticals . Arnold R. Sykes claims in his Pradaxa lawsuit

Pradaxa Rival Medication Rejected by FDA

Thu, Jul 05, 2012 18:00 CET

What does it say about how dangerous Pradaxa may be when a competing drug that is expected by some to be the best anticoagulant on the market is denied by the Food and Drug Administration? The FDA announced earlier this week that Eliquis

Pradaxa Rival Medication As Effective as Aspirin, Says Study

Tue, Jun 26, 2012 22:00 CET

The debate over the effectiveness of blood-thinning medications rages on, as a newly released report is now claiming that aspirin is as effective in treating blood clots as is warfarin, the drug that Pradaxa is seeking to replace. The report, which was undertaken at New York Presbyterian Hospital/Columbia University Medical Center and will be published in the New

Is Pradaxa Dangerous if Mixed with Cranberry Juice?

Thu, Jun 21, 2012 00:30 CET

It has long been documented that one of the most dangerous aspects of blood thinner medications – be it an older version like warfarin or a newer one like Pradaxa – is their tendency to mix negatively with other medications and create a potentially dangerous reaction. However, it turns out negative reactions may not only be caused by reactions with other drugs. A recent question posed by an anticoagulant drug user in the syndicated People’s Pharmacy

Pradaxa Tops List of Dangerous Drugs in 2011

Sat, Jun 09, 2012 18:20 CET

Consumers and health professionals singled out the dangers of Pradaxa (Dabigatran)to the Food and Drug Administration more any other medication in 2011, further underscoring the concerns of many that the blood thinner is unsafe. The QuarterWatch medical surveillance program,

There are no items matching the current filter

There are no more items matching the current filter

Share